Gilead Sciences announced a significant milestone: the U.S. FDA accepted their New Drug Applications (NDAs) for lenacapavir ...
Researchers led by Imperial have unveiled primary trial results that show encouraging advances in HIV treatment driven by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback